Lead Manager/ | # of | Price Range | Dollar | SCOOP | ||
New Filings (Proposed Symbol) | Joint-Lead Managers | Shares | Low | High | Volume | Ratings |
ConnectOne Bancorp (CNOB) | Stifel Nicolaus Weisel | $57.50 | n.a. | |||
The ExOne Company (XONE) | FBR | $75.00 | n.a. | |||
XOOM (XOOM) | Barclays/ Needham | $50.00 | n.a. | |||
ZAIS Financial (ZFC) | Deutsche Bank Securities/ Citigroup/ Barclays/ Credit Suisse | $140.00 | n.a. | |||
n.a. (not available) | ||||||
Postponed | ||||||
None | ||||||
Withdrawn | ||||||
None | ||||||
New Terms | ||||||
CVR Refining, LP (CVRR) | Credit Suisse/ Citigroup | 20.00 | $24.00 | $26.00 | $500.00 | 2-Stars |
CyrusOne (CONE) | Morgan Stanley/ BofA Merrill Lynch | 16.50 | $16.00 | $18.00 | $280.50 | 1-Star |
LipoScience (LPDX.) | Barclays Capital/ UBS Investment Bank/ Piper Jaffray | 5.00 | $13.00 | $15.00 | $70.00 | n.a. |
Norwegian Cruise Line Holdings (NCLH) | UBS Investment Bank/ Barclays/ Citigroup/ Deutsche Bank Securities/ Goldman, Sachs/ J.P. Morgan | 25.53 | $16.00 | $18.00 | $434.00 | 1-Star |
Stemline Therapeutics (STML) | Aegis Capital | 2.28 | $10.00 | $12.00 | $25.03 | 1-Star |
SunCoke Energy Partners, L.P. (SXCP) | Barclays/ BofA Merrill Lynch/ Citigroup/ Credit Suisse/ J.P. Morgan | 13.50 | $19.00 | $21.00 | $270.00 | 2-Stars |
USA Compression Partners, LP (USAC) | Barclays Capital/ Goldman, Sachs/ J.P. Morgan/ Wells Fargo Securities | 10.00 | $19.00 | $21.00 | $200.00 | 2-Stars |
IPOs Priced | Lead | Shares | Amount | Offer | Close | % |
Week of Jan. 7, 2013 | Manager(s) | Offered | Raised | Price | 1/11/13 | Change |
None |